Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Nippon Shinyaku
Welcome,
Profile
Billing
Logout
18 Products
111 Diseases
18 Products
271 Trials
9713 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
30
60
90
120
150
180
210
240
270
300
Gazyva
(obinutuzumab) / Roche, Biogen, Nippon Shinyaku
Vyxeos
(cytarabine/daunorubicin liposomal formulation) / Jazz, Nippon Shinyaku
Opsumit
(macitentan) / Nippon Shinyaku, J&J
Emcyt
(estramustine) / Pfizer, Nippon Shinyaku
Uptravi
(selexipag) / J&J, Nippon Shinyaku
Fintepla
(low-dose fenfluramine) / UCB, Nippon Shinyaku
Campral EC
(acamprosate delayed release) / EMD Serono, Nippon Shinyaku
Amnolake
(tamibarotene) / Syros
Elzonris
(tagraxofusp-erzs) / Menarini, Nippon Shinyaku
buloxibutid
(C21) / Vicore Pharma
Viltepso
(viltolarsen) / Nippon Shinyaku
NS-089/NCNP-02
/ Nippon Shinyaku, National Center of Neurology and Psychiatry
Uptravi Injection
(selexipag IV) / J&J, Nippon Shinyaku
ilginatinib
(NS-018) / Nippon Shinyaku
radgocitabine
(DFP-10917) / Delta-Fly Pharma
NS-229
/ Nippon Shinyaku
afacifenacin fumarate
(SMP-986) / Sumitomo Pharma, Nippon Shinyaku
